Induction of vascular cell adhesion molecule-1 by low-density lipoprotein

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Atherosclerosis Research

Background:

• Low-density lipoprotein (LDL) is a known risk factor for atherosclerosis.
• Endothelial cell activation by LDL contributes to monocyte recruitment and plaque formation.

Purpose of the Study:

• To investigate the link between LDL and the induction of vascular cell adhesion molecule-1 (VCAM-1) in endothelial cells.
• To elucidate the molecular mechanisms underlying LDL-induced VCAM-1 expression.

Main Methods:

• Incubation of endothelial cells with pathophysiologic amounts of human LDL.
• Analysis of VCAM-1 mRNA levels and promoter activity.
• Assessment of transcription factor binding (NF-kappa B, AP-1, GATA) using electrophoretic mobility shift assays.
• Inhibition studies using anti-VCAM antibodies.

Main Results:

• Human LDL induces VCAM-1 transcription and increases mRNA levels via VCAM promoter activation.
• LDL-induced VCAM-1 expression is blocked by anti-VCAM antibodies.
• While NF-kappa B binding remains basal, LDL increases AP-1 and GATA binding activities.
• LDL enhances endothelial cell recruitment of monocytes, mediated by VCAM-1 expression through AP-1 and GATA.

Conclusions:

• LDL acts as a VCAM-1 inducer in endothelial cells, potentially through mechanisms distinct from cytokines and endotoxin.
• LDL-mediated VCAM-1 expression, regulated by AP-1 and GATA, contributes to monocyte recruitment in atherogenesis.